SBW Life Sciences Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported negative sales was KRW 168.45 million compared to sales of KRW 79.85 million a year ago. Net loss was KRW 1,103.2 million compared to net income of KRW 1,126.57 million a year ago. Basic loss per share from continuing operations was KRW 6 compared to basic earnings per share from continuing operations of KRW 6 a year ago. Diluted loss per share from continuing operations was KRW 6 compared to diluted earnings per share from continuing operations of KRW 6 a year ago. Basic loss per share was KRW 6 compared to basic earnings per share of KRW 6 a year ago.
For the nine months, sales was KRW 1,247.49 million compared to KRW 79.85 million a year ago. Net loss was KRW 869.42 million compared to KRW 7,395.36 million a year ago. Basic loss per share from continuing operations was KRW 5 compared to KRW 42 a year ago. Diluted loss per share from continuing operations was KRW 5 compared to KRW 42 a year ago. Basic loss per share was KRW 5 compared to KRW 42 a year ago.